Lv1
20 积分 2025-06-05 加入
Cost-Effectiveness of Adding Dapagliflozin and Empagliflozin to Standard Treatment for Diabetic Kidney Disease in China
3小时前
求助中
Cost‐effectiveness of canagliflozin and dapagliflozin for treatment of patients with chronic kidney disease and type 2 diabetes
3小时前
已完结
Cost Effectiveness of Dapagliflozin Added to Standard of Care for the Management of Diabetic Nephropathy in the USA
4小时前
已完结
Vericiguat versus sacubitril/valsartan for the treatment of heart failure with reduced ejection fraction in China: a cost-utility analysis
4个月前
已完结
Vericiguat for the Treatment of Heart Failure with Reduced Ejection Fraction Following a Worsening Heart Failure Event: A Cost-Effectiveness Analysis from the Perspective of Chinese Healthcare Providers
4个月前
已完结
EE381 Comparative Cost Effectiveness of Dapagliflozin and Empagliflozin in Heart Failure with Reduced Ejection Fraction
5个月前
已关闭
Cost-effectiveness of dapagliflozin and empagliflozin for treatment of heart failure with reduced ejection fraction
5个月前
已完结
皖公网安备34019202002308
